Literature DB >> 29036718

Glutamatergic Response to Heat Pain Stress in Schizophrenia.

Joshua Chiappelli1, Qiaoyun Shi1, Sarah Andrea Wijtenburg1, Raimi Quiton2, Krista Wisner1, Frank Gaston1, Priyadurga Kodi1, Christopher Gaudiot1, Peter Kochunov1, Laura M Rowland1,2, Liyi Elliot Hong1.   

Abstract

Regulation of stress response involves top-down mechanisms of the frontal-limbic glutamatergic system. As schizophrenia is associated with glutamatergic abnormalities, we hypothesized that schizophrenia patients may have abnormal glutamatergic reactivity within the dorsal anterior cingulate cortex (dACC), a key region involved in perception of and reaction to stress. To test this, we developed a somatic stress paradigm involving pseudorandom application of safe but painfully hot stimuli to the forearm of participants while they were undergoing serial proton magnetic resonance spectroscopy to measure changes in glutamate and glutamine levels in the dACC. This paradigm was tested in a sample of 21 healthy controls and 23 patients with schizophrenia. Across groups, glutamate levels significantly decreased following exposure to thermal pain, while ratio of glutamine to glutamate significantly increased. However, schizophrenia patients exhibited an initial increase in glutamate levels during challenge that was significantly different from controls, after controlling for heat pain tolerance. Furthermore, in patients, the acute glutamate response was positively correlated with childhood trauma (r = .41, P = .050) and inversely correlated with working memory (r = -.49, P = .023). These results provide preliminary evidence for abnormal glutamatergic response to stress in schizophrenia patients, which may point toward novel approaches to understanding how stress contributes to the illness.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29036718      PMCID: PMC6007227          DOI: 10.1093/schbul/sbx133

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  61 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

2.  Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal.

Authors:  Joshua P Johansen; Howard L Fields
Journal:  Nat Neurosci       Date:  2004-03-07       Impact factor: 24.884

3.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.

Authors:  Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

4.  Use of tissue water as a concentration reference for proton spectroscopic imaging.

Authors:  Charles Gasparovic; Tao Song; Deidre Devier; H Jeremy Bockholt; Arvind Caprihan; Paul G Mullins; Stefan Posse; Rex E Jung; Leslie A Morrison
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

5.  Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex.

Authors:  G Treccani; L Musazzi; C Perego; M Milanese; N Nava; T Bonifacino; J Lamanna; A Malgaroli; F Drago; G Racagni; J R Nyengaard; G Wegener; G Bonanno; M Popoli
Journal:  Mol Psychiatry       Date:  2014-02-18       Impact factor: 15.992

6.  Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy.

Authors:  S Andrea Wijtenburg; Jack Knight-Scott
Journal:  J Magn Reson Imaging       Date:  2011-07-14       Impact factor: 4.813

7.  A novel technique to study the brain's response to pain: proton magnetic resonance spectroscopy.

Authors:  Paul G Mullins; Laura M Rowland; Rex E Jung; Wilmer L Sibbitt
Journal:  Neuroimage       Date:  2005-06       Impact factor: 6.556

Review 8.  Does the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia?

Authors:  Dina Collip; Inez Myin-Germeys; Jim Van Os
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

Review 9.  Pathways to schizophrenia: the impact of environmental factors.

Authors:  Oliver D Howes; Colm McDonald; Mary Cannon; Louise Arseneault; Jane Boydell; Robin M Murray
Journal:  Int J Neuropsychopharmacol       Date:  2004-03       Impact factor: 5.176

Review 10.  Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies.

Authors:  Stéphane Potvin; Serge Marchand
Journal:  Pain       Date:  2007-12-21       Impact factor: 6.961

View more
  5 in total

1.  Human brain functional MRS reveals interplay of metabolites implicated in neurotransmission and neuroenergetics.

Authors:  Yury Koush; Douglas L Rothman; Kevin L Behar; Robin A de Graaf; Fahmeed Hyder
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-26       Impact factor: 6.960

2.  Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.

Authors:  Robert A McCutcheon; John H Krystal; Oliver D Howes
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

3.  Imaging Brain Glx Dynamics in Response to Pressure Pain Stimulation: A 1H-fMRS Study.

Authors:  Luke A Jelen; David J Lythgoe; Jade B Jackson; Matthew A Howard; James M Stone; Alice Egerton
Journal:  Front Psychiatry       Date:  2021-07-28       Impact factor: 4.157

4.  Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.

Authors:  Jason Smucny; Cameron S Carter; Richard J Maddock
Journal:  Biol Psychiatry       Date:  2021-06-12       Impact factor: 12.810

5.  Metabolite activity in the anterior cingulate cortex during a painful stimulus using functional MRS.

Authors:  J Archibald; E L MacMillan; C Graf; P Kozlowski; C Laule; J L K Kramer
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.